Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (511-520 of 6,828) with videos related to

Pageof 683
Sort By:
Nature Reviews. Drug Discovery|February 18, 2022
LAG3 pushes immuno-oncology's leading edgeAsher Mullard
Nature Reviews. Drug Discovery|October 5, 2021
Merck & Co. to buy Acceleron and its TGF-β ligand trapsAsher Mullard
Nature Reviews. Drug Discovery|October 5, 2021
Novel excipient review programme aims to bolster formulation innovationAsher Mullard
Nature Reviews. Drug Discovery|May 4, 2019
Innovative antidepressants arriveAsher Mullard
Nature Reviews. Drug Discovery|October 30, 2021
ALS antisense drug falters in phase IIIAsher Mullard
Nature Reviews. Drug Discovery|April 9, 2022
FDA approves first PSMA-targeted radiopharmaceuticalAsher Mullard
Nature Reviews. Drug Discovery|August 31, 2018
Can you trust your cancer cell lines?Asher Mullard
Nature Reviews. Drug Discovery|October 2, 2021
Gene therapy community grapples with toxicity issues, as pipeline maturesAsher Mullard
Nature Reviews. Drug Discovery|March 12, 2022
Proof-of-principle Intellia trial shows in vivo CRISPR activityAsher Mullard
Nature Reviews. Drug Discovery|March 15, 2022
Antibody clamps pry open small-molecule drug discovery opportunitiesAsher Mullard
Pageof 683

Showing results (511-520 of 6,828) with videos related to

Sort By:
Pageof 683
Nature Reviews. Drug Discovery|February 18, 2022
LAG3 pushes immuno-oncology's leading edgeAsher Mullard
Nature Reviews. Drug Discovery|October 5, 2021
Merck & Co. to buy Acceleron and its TGF-β ligand trapsAsher Mullard
Nature Reviews. Drug Discovery|October 5, 2021
Novel excipient review programme aims to bolster formulation innovationAsher Mullard
Nature Reviews. Drug Discovery|May 4, 2019
Innovative antidepressants arriveAsher Mullard
Nature Reviews. Drug Discovery|October 30, 2021
ALS antisense drug falters in phase IIIAsher Mullard
Nature Reviews. Drug Discovery|April 9, 2022
FDA approves first PSMA-targeted radiopharmaceuticalAsher Mullard
Nature Reviews. Drug Discovery|August 31, 2018
Can you trust your cancer cell lines?Asher Mullard
Nature Reviews. Drug Discovery|October 2, 2021
Gene therapy community grapples with toxicity issues, as pipeline maturesAsher Mullard
Nature Reviews. Drug Discovery|March 12, 2022
Proof-of-principle Intellia trial shows in vivo CRISPR activityAsher Mullard
Nature Reviews. Drug Discovery|March 15, 2022
Antibody clamps pry open small-molecule drug discovery opportunitiesAsher Mullard
Pageof 683